This policy brief examines how the U.S. healthcare system contributes to the rising cost of prescription drugs and the growing affordability crisis. It explains why the pharmaceutical market is failing, looks at key issues such as patent practices, limited generic competition, and pay-for-delay agreements, and proposes policy solutions to increase competition and make prescription medications more affordable.

Published by   

   on   

October 21, 2026